Nov 29 (Reuters) - United Therapeutics Corp UTHR.O :
* HEALTH CANADA APPROVES UNITUXIN® FOR THE TREATMENT OF PEDIATRIC HIGH-RISK NEUROBLASTOMA
* UNITED THERAPEUTICS CORP - SAFETY INFORMATION FOR UNITUXIN CONTAINS BOXED WARNING ABOUT SERIOUS INFUSION REACTIONS